BeOne Medicines (ONC) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for BeOne Medicines (ONC) over the last 9 years, with Q3 2025 value amounting to $0.08.
- BeOne Medicines' EPS (Weighted Average and Diluted) rose 18888.89% to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.03, marking a year-over-year increase of 10468.75%. This contributed to the annual value of -$0.47 for FY2024, which is 2769.23% up from last year.
- BeOne Medicines' EPS (Weighted Average and Diluted) amounted to $0.08 in Q3 2025, which was up 18888.89% from $0.06 recorded in Q2 2025.
- BeOne Medicines' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.15 during Q3 2023, with a 5-year trough of -$0.49 in Q4 2021.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.26 (2023), whereas its average is -$0.19.
- In the last 5 years, BeOne Medicines' EPS (Weighted Average and Diluted) tumbled by 76000.0% in 2022 and then soared by 18888.89% in 2025.
- BeOne Medicines' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.49 in 2021, then skyrocketed by 32.65% to -$0.33 in 2022, then rose by 18.18% to -$0.27 in 2023, then surged by 59.26% to -$0.11 in 2024, then skyrocketed by 172.73% to $0.08 in 2025.
- Its last three reported values are $0.08 in Q3 2025, $0.06 for Q2 2025, and $0.0 during Q1 2025.